Mode of Action of Anti-diabetic Phyto-Compounds Present in Traditional Indian Plants: A Review

Main Article Content

Divya Jain
Kiran Bains
Neerja Singla

Abstract

The traditionally used plants having therapeutically potent phyto-chemicals are known to have a great potential in the treatment of various ailments including the non-communicable ones like obesity, diabetes, hypertension, heart diseases etc. Diabetes is a serious metabolic disorder affecting a large number of population worldwide.  Despite the great efforts made to understand and manage this disorder, its prevalence is increasing unabatedly which creates an upsurging demand for some other approach than conventional medicines. The use of many traditional plants with anti-diabetic potential is being considered as an alternate strategy, which is cost-effective and has less side effects. This paper reviews the accumulated literature mainly for five Indian herbs having anti-diabetic activity and their proposed action of mechanism which has been scientifically tested. Phyto-compounds present in medicinal plants like gurmur (Gymnema Sylvestre), cinnamon (Cinnamomum), sea buckthorn (Hippophae rhamnoides), mulberry leaves (Moraceae Plant) and fenugreek (Trigonella foenum-graecum) have shown significant hypoglycemic potential in treating type 2 diabetes through several possible mechanisms. Gymnemic acid in gurmur can inhibit the intestinal glucose absorption, whereas cinnamaldehyde in cinnamon and palmitoleic acid in Sea buckthorn enhances glucose uptake. The compound 1-deoxynojirimycin found in mulberry leaves inhibits the enzymatic activity of α-glucosidase and diosgenin in Fenugreek has a role in the regeneration of pancreatic β-cells, thus showing the mechanism of their anti-diabetic action. The inclusion of these medicinal plants in daily dietaries can be looked upon as an alternate strategy towards controlling and managing blood glucose levels among people with diabetes.

Keywords:
Traditional medicinal plants, phyto-compounds; diabetes mellitus, anti-diabetic action, hypoglycemic effect.

Article Details

How to Cite
Jain, D., Bains, K., & Singla, N. (2020). Mode of Action of Anti-diabetic Phyto-Compounds Present in Traditional Indian Plants: A Review. Current Journal of Applied Science and Technology, 39(21), 19-38. https://doi.org/10.9734/cjast/2020/v39i2130819
Section
Review Article

References

Plum L, Belgardt BF, Bruning JC. Central insulin action in energy and glucose homeostasis. J Clin Invest. 2006;116(7): 1761-66.

Araleimath VR, Bhise SB. Antidiabetic effect of Gymnema sylvestre extract on streptozotocin induced diabetic rats and possible β-cell protective and regenerative evaluation. Dig J Nanomater Bios. 2012;7 (1):135-42.

IDF. Diabetic facts and figures. International Diabetes Federation Report, Diabetes Atlas 9th Edition; 2019.

Tiwari AK, Rao J. Diabetes mellitus and multiple therapeutic approaches of phytochemicals: present status and future perspective. Curr Sci. 2002;83(1):30-38.

Kaveeshwar SA, Cornwall J. The current state of diabetes mellitus in India. Aust Med J. 2014;7(1):45-48.

IDF. India: International Diabetes. International Diabetes Federation; 2020.

Available:https://idf.org/our-network/regions-members/south-east-asia/members/94-india.html

Dhal NK, Panda SS, Muduli SD. Traditional uses of medicinal plants by native people in Nawarangpur district, Odisha, India. Asian J Plant Sci. 2015; 5(2):27-33.

Sin Oh. Plant derived compounds targeting pancreatic beta cells for the treatment of diabetes; 2015.

Available:http:// dx.doi.org/10.1155/2015/629863

Sun C, Zhoa C, Guven EC, Paoli P, Simal-Gandara J, Mohanram K, Ramkumar Wang S, et al. Dietary polyphenols as antidiabetic agents: advances and opportunities. Food Frontier. 2020;1-27. Available;https://doi.org/10.1002/fft2.15

Teodoro AJ. Bioactive compounds of food: their role in the prevention and treatment of diseases. Oxid Med Cell Longiv; 2019.

Available:https://doi.org/10.1155/2019/3765986

Gothai S, Gabesan SY Park, Fakurazi S, Choi DK, Arulselvan P. Natural phyto-bioactive compounds for treatment of type 2 diabetes: inflammation as a target. Nutrients. 2016;8(8):61.

Choudhury H, Pandey M, Hua CK, Mun CS, et al. An update on natural compounds in the remedy of diabetes mellitus: a systematic review. J Tradit Complement Med. 2017;1-16. Cited from: DOI:10.1080/13543776.2019.1648434

Baquer NZ, Kumar P, Taha A, Kale RK, Cowsik SM, McLean P. Metabolic and molecular action of Trigonella foenum-graecum (fenugreek) and trace metals in experimental diabetic tissues. J Biosci. 2011;36(2):383-96.

Laha S, Paul S. Gymnema sylvestre (Gurmar): a potent herb with antidiabetic and antioxidant potential. Pharmacogn J. 2019;11:201-06.

Peng X, Cheng KW, Ma J, Lo C, et al. Cinnamon bark proanthocyanidines as reactive carbonyl scavengers to prevent the formation of advanced glycation end product. J Agric Food Chem. 2008;56: 1907-11.

Available:https://pubmed.ncbi.nlm.nih.gov/18284204/

Saneja A, Sharma C, Aneja K, Pahwa R. Gymnema sylvestre (Gurmar): A review. Der Pharmacia Lettre. 2010;2:275-84.

Sharma P. Dravya guna vigyan, 17th ed. Varanasi, India: Chaukhamba Vishvabharti; 1996;2.

Thaifa MS, Roshna S, Arya US, Aparna G. A review on diabetes mellitus and diabetic neuropathy: A plant based approach. J Pharmacogn Phytochem. 2017;6(3):506-10.

Murakami N, Murakami T, Kadoya M. New hypogylcemic constituents in ‘gymnemic acid’ from Gymnema sylvestre. Chem Phar Bul. 1996;45:141-45.

Pierce A. Gymnema Monograph: Practical guide to natural medicine. Stonesong Press Book, New York. 1999;324-26.

Parveen S, Chester K, Husain S. Bioactive principles of Gymnema sylvestre R. Br. from yesterday’s tradition to tomorrow’s drug; 2016.

Available:https://www.semanticscholar.org/paper/Bioactive-principles-of-Gymnema-sylvestre-R-.-Br-.-Parveen-Chester/70d465cf79e3050e85097fbaa7c3e67c000d2276

Kumar D, Mitra A, Manjunatha M. In vitro and in vivo studies of antidiabetic Indian medicinal plants: A review. J Herbal Med Toxic. 2009;3(2):9-14.

Sugijara Y, Nojima H, Matsuda H, Murakami T, Yoshikawa M, Kimura I. Antihyperglycemic effect of gymnemic acid IV, a compound derived from Gymnema Sylvestre leaves in steptozotocin diabetic mice. J Asian Nat Prod Res. 2000;2:321-27.

Al-Romaiyan A, Liu B, Asare-Anane H, Maity CR, Chatterjee SK, Koley N, Biswas T, Chatterji AK, et al. A novel Gymnema sylvestre extract stimulates insulin secretion from human islets in vivo and in vitro. Phytother Res. 2010;24:1370-76.

Available: https://pubmed.ncbi.nlm.nih.gov/ 20812281/

Paliwal R, Kothari, Upadhyay B. Effect of gurmar (Gymnema sylvestre) powder intervention on the blood glucose levels among diabetics. Stud Ethno Med. 2009;3:133-35.

Ishijima S, Takashma T, Ikemura T, Izutani Y. Gymnremic acid interacts with mammalian glycerol-3-phosphatedehydrogenase. Mol Cell Biochem. 2008;310(1-2):203-08.

Joffee DJ, Freed SH. Effect of extended release Gymnema sylvestre leaf extract alone or in combination with oral hypogylcemics or insulin regimens for type 1 and type 2 diabetes. Diabetes Control Newsletter. 2001;76:30.

Sangal A. Role of cinnamon as beneficial antidiabetic food adjunct: A review. Adv Appl Sci Res. 2011;2(4):440-50.

Sahib AS. Anti-diabetic and antioxidant effect of cinnamon in poorly controlled type-2 diabetic Iraqi patients: A randomized, placebo-controlled clinical trial. J Intercult Ethnopharmacol. 2016;5 (2):208-13.

Brahmachari S, Jana A, Pahan K. Sodium benzoate, a metabolite of cinnamon and a food additive, reduces microglial and astroglial inflammatory responses. J Immunol. 2009;183(9):5917-27.

Aggarwal B. Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals. Annu Rev Nutr. 2010;30:173–99.

Thomas J, Duethi P, Peter KV. Handbook of herbs and spices. Woodhead Publishing Ltd, England. 2001;143-153.

Verspohl EJ, Bauer K, Neddermann E. Antidiabetic effect of Cinnamomum cassia and Cinnamomum zeylanicum in vivo and in vitro. Phytother Res. 2005;19(3):203-06.

Davis PA, Yokoyama W. Cinnamon intake lowers fasting blood glucose: Meta-analysis. J Med Food. 2011;14:884-89.

Anand P, Murali KY, Tandon V, Murthy PS, Chandra R. Insulinotropic effect of cinnamaldehyde on transcriptional regulation of pyruvate kinase, phosphoenol pyruvate carboxykinase and GLUT4 translocation in experimental diabetic rats. Chemico-Biological Interaction. 2010;186:72–81.

Yamada K, Noguchi T. Nutrient and hormonal regulation of pyruvate kinase gene expression. Biochem J. 1999;337:1-11.

Goldfine ID. The insulin receptor: molecular biology and transmembrane signalling. Endocrinol Rev. 1987;8(3):235-55.

Patel DK, Prasad SK, Hemlatha S. An overview on antidiabetic medicinal plants having insulin mimetic property. Asian Pac J Trop Biomed. 2012;320-30.

Taher M, Fadzilah Adibah AM, Mohomad RS. A proanthocyanidin from Cinnamomum zeylanicum stimulates phosphorylation of insulin receptor in 3 T3-L1 adipocytes. J Tech. 2006;44:53-68.

Khan A, Sadafar M, Ali Khan MM, Khattak KN, Anderson RA. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care. 2003;26(12): 3215-18.

Kadan S, Saad B Sasson Y, Zaid H. In vitro evaluations of cytotoxicity of eight antidiabetic medicinal plants and their effect on GLUT4 translocation. Evidence based- Complement Alter Med. 2013;1-9.

Dhyani D, Maikhuri RK, Rao KS, Kumar L, Purohit VK, Sundriyal M, Saxena KG. Basic nutritional attributes of Hippophae rhamnoides (sea buckthorn) populations from Uttarakhand Himalaya India. Curr Sci. 2007;92:1148-52.

Kallio H, Yang B, Peippo P. Effects of different origins and harvesting time on vitamin C, tocopherols, and tocotrienols in sea buckthorn (Hippophae rhamnoides) berries. J Agric Food Chem. 2002;50: 6136-42.

Kalia RK, Singh R, Rai MK, et al. Biotechnological interventions in sea buckthorn (Hippophae L): Current status and future prospects. Trees. 2011;25(4): 559-75.

Singh IP, Ahmad F, Gore DD, Tikoo K, Bansal A, Jachak SM, Jena G. Therapeutic potential of seabuckthorn: a patent review (2000-2018). Expert Opinion on Therapeutic Patent; 2019.

Talbot NA, Wheeler-Jones CP, Cleasby ME. Palmitoleic acid prevents palmitic acid-induced macrophage activation and consequent P38 MAPK-mediated-skeletal muscle insulin resistance. Mol Cell Endocrinol. 2014;393:129−42.

Cao H, Gerhold K, Mayers JR, Wiest MM, Watkins SM, Hotamisligil GS. Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cell. 2008;134:933-44.

Zong G, Ye X, Sun L, Li H, Yu Z, Hu FB, Sun Q, Lin X. Associations of erythrocyte palmitoleic acid with adipokines, inflammatory markers, and the metabolic syndrome in middle-aged and older Chinese. Am J Clin Nutr. 2012;96:970-76.

Bolsoni-Lopes A, Festuccia WT, Chimin P, Farias TS, Torres-Leal FL, Cruz MM, Andrade PB, et al. Palmitoleic acid (n-7) increases white adipocytes GLUT4 content and glucose uptake in association with AMPK activation. Lipids Health Dis. 2014;13:199.

Available:https:// pubmed.ncbi.nlm.nih.gov/25528561/

Gao S, Guo Q, Qin C, Shang R, Zhang Z. Sea buckthorn fruit oil extract alleviates insulin resistance through the PI3K/Akt signaling pathway in type 2 diabetes mellitus cells and rats. J Agric Food Chem. 2017;65(7):1328-36.

Sharma M, Siddique MW, Shamim AK, Gyanesh S, Pillai KK. Evaluation of antidiabetic and antioxidant effects of seabuckthorn (Hippophae rhamnoides L.) in Streptozotocin-Nicotinamide induced diabetic rats. Open Conf Proc J. 2011;2:53-58.

Zhang W, Zhao J, Wang J, Pang X, Zhuang X, Zhu X, Qu W. Hypoglycemic effect of aqueous extract of seabuckthorn (Hippophae rhamnoides L.) seed residues in streptozotocin-induced diabetic rat. Phytother Res. 2010;24:228-32.

Lehtonen HM, Suomela JP, Tahvonen R, Yang B, Venojarvi M, Viikari J, Kallio H. Different berries and berry fractions have various but slightly positive effects on the associated variables of metabolic diseases on overweight and obese women. Eur J Clin Nutr. 2011;65(3):394-401.

Joanta AE, Sarlea SV, Login C, Socaciu C, Decea N, Moldovan R, Damian A. Hippophae rhamnoides interferes with insulin release via L-type Ca2+ channel-mediated pathway in rat islet β cells. Bull UASMV Vet Med. 2009;1:207-13.

Pang X, Zhao J, Zhang W, Zhuang X, Wang J, Xu R, Xu Z, Qu W. Antihypertensive effect of total flavones extracted from seed residues of Hippophae rhamnoides L. in sucrose-fed rats. J Ethnopharmacol. 2008;117(2):325-31.

Bell GI. Molecular defects in diabetes mellitus. Diabetes. 1991;40:413–17.

Akbas SH, Yegin A, Ozben T. Effect of pentylenetetrazol induced epileptic seizure on the antioxidant enzyme activities, glutathione and lipid peroxidation levels in rat erythrocytes and liver tissues. Clin Biochem. 2005;38:1009–14.

Shan XQ, Aw TY, Jones DP. Glutathione-dependent protection against oxidative injury. Pharmacol Ther. 1990;47:61–71.

Sanchez MD. Mulberry: An exceptional forage available almost worldwide. World Anim Rev. 2000;93:1–21.

Srivastava S, Kapoor R, Thathola A, Srivastava RP. Nutritional quality of leaves of some genotypes of mulberry (Morus alba). Int J Food Sci Nutr. 2006;57:305-13.

Chan EW, Lye PY, Wong SK. Phytochemistry, pharmacology, and clinical trials of Morus alba. Chin J Nat Med. 2016;14:17-30.

Hansawasdi C, Kawabata J. α-Glucosidase inhibitory effect of mulberry (Morus alba) leaves on Caco-2. Fitoterapia. 2006;77:568-73.

Zhang L, Su S, Zhu Y, Guo J, Qian D, Ouyang Z, Duan J. Mulberry leaf active components alleviate type 2 diabetes and its liver and kidney injury in db/db mice through insulin receptor and TGF-β/Smads signaling pathway. Biomed Pharmacother. 2019;112:108675.

Thaipitakwong T, Numhom S, Aramwit P. Mulberry leaves and their potential effects against cardiometabolic risks: a review of chemical compositions, biological properties and clinical efficacy. Pharma Biol. 2018;56(1):109-18.

Park JM, Bong HY, Jeong HI, Kim YK, Kim JY, Kwon O. Postprandial hypoglycemic effect of mulberry leaf in Goto-Kakizaki rats and counterpart control Wistar rats. Nutr Res Pract. 2009;3:272–78.

Kim GN, Kwon YI, Jang HD. Mulberry leaf extract reduces postprandial hyperglycemia with few side effects by inhibiting α-glucosidase in normal rats. J Med Food. 2011; 14: 712-17.

Mohammadi J, Naik PR. Evaluation of hypoglycemic effect of Morus alba in an animal model. Indian J Pharmacol. 2008;40:15-18.

Miyahara C, Miyazawa M, Satoh S, Sakai A, Mizusaki S. Inhibitory effects of mulberry leaf extract on postprandial hyperglycemia in normal rats. J Nutr Sci Vitaminol. 2004;50:161-64.

Li YG, Ji DF, Zhong S, Lin TB, Lv QZ, Hu GY, Wang X. 1-Deoxynojirimycin inhibits glucose absorption and accelerates glucose metabolism in streptozotocin induced diabetic mice. Sci Rep. 2013;3:1377.

Deng MJ, Lin XD, Wen CW, Dong MJ, Lin QT, Zhang SZ, Xu JP. Metabolic changes in the midgut of Eri silkworm after oral administration of 1-deoxynojirimycin: A 1H-NMR-based metabonomic study. PLoS One. 2017;12:e0173213.

Kothapalli D, Grotendorst GR. CTGF modulates cell cycle progression in camp arrested nrk fibroblasts. J Cell Physiol. 2015;182:119-126.

Sakoda H, Ogihara T, Anai M, Funaki M, Inukai K, Katagiri H, Fukushima Y, Onishi Y, Ono H, Fujishiro M. Dexamethasone-induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction. Diabetes. 2000;49(10):1700.

Meng Q, Qi X, Chao Y, Chen Q, Cheng P, Yu X, Kuail M, et al. IRS1/PI3K/AKT pathway signal involved in the regulation of glycolipid metabolic abnormalities by Mulberry (Morus alba L.) leaf extracts in 3T3‑L1 adipocytes. Chin Med. 2020;15:1. Available:https://pubmed.ncbi. nlm.nih.gov/31908653/

Andallu B, Vardacharyulu N. Effect of mulberry leaves on diabetes. Int J Dev Countries. 2001;21:147-51.

Andallu B, Vardacharyulu N. Gluconeogenic substrates and hepatic gluconeogenic enzymes in streptozotocin-diabetic rats: effect of mulberry (Morus indica L.) leaves. J Med Food. 2007;10(1):41-48.

Mohammadi J, Naik PR. The histopathologic effects of Morus alba leaf extract on the pancreas of diabetic rats. Turk J Biol. 2012;36:211–16.

Mudra M, Ercan-Fang N, Zhong L, Furne J, Levitt M. Influence of mulberry leaf extract on the blood glucose and breathe hydrogen response to ingestion of 75 g sucrose by type 2 diabetic and control subjects. Diabetes Care.2007;30:1272–12.

Kirtikar KR, Basu BD. Indian Medicinal Plants, 3rd revised ed. Lalit Mohan Prakashan Allahabad, India; 2000.

Chauhan A, Sharma PK, Srivastava P, Dudhe R. Plants having potential antidiabetic activity: a review. Der Pharmacia Lettre. 2010;2(3):369-87.

Fuller S, Stephens JM. Diosgenin, 4-hydroxyisoleuicine and fibre from fenugreek: mechanisms of actions and potential effects on metabolic syndrome. Adv Nutr. 2015;6:189-97.

Srinivasan K. Plant foods in the management of diabeties mellitus: spices as beneficial antidiabetic food adjuncts. Int J Food Sci Nutr. 2005;56:399-414.

Uemura T, Hirai S, Mizoguchi N, Goto T, Lee J Y, Taketani K et al. Diosgenin present in fenugreek improves glucose metabolism bt promoting adipocyte differentiation and inhibiting inflammation in adipose tissues. Mol Nutr Food Res. 2010;54:1596-1608.

Bera TK, Ali KM, Jana K, Ghosh A, Ghosh D. Protective effect of aqueous extract of seed of Psoralea corylifolia (Somraji) and seed of Trigonella foenum-graecum L. (Methi) in streptozotocin-induced diabetic rat: A comparative evaluation. Pharmacognosy Res. 2013;5:277-85.

Kaczmar T. Herbal support for diabetes management. Clin Nutr Insights. 1998; 6(8): 1-4.

Jette L, Harvey L, Eugeni K, Levens N. 4-Hydroxyisoleucine: a plant derived treatment for metabolic syndrome. Curr Opin Investig Drugs. 2009;10:353-58.

Gupta A, Gupta R, Lal B. Effect of Trigonella foenum-graecum (Fenugreek) seeds on glycemic control and insulin resistance in type 2 diabetes mellitus: A double blinded controlled study. J Assoc Physicians India. 2001;49:1057-61.

Sauvaire Y, Petit P Broca C, Manteghetti M , Baissac Y, Fernandez-Alvarez J, Gross R, Roye M, Leconte A, Ribes G. 4-Hydroxyisoleucine: A novel aminoacid potentiator of insulin secretion. Diabetes. 1998;47:206-10.

Available:https://pubmed.ncbi.nlm.nih.gov/9519714/

Hannan JM, Ali L, Rokeya B, Khaleque J, Akhter M, et al. Soluble dietary fibre fraction of (fenugreek) seeds improves glucose homeostasis in animal models of type 1 and type 2 diabetes by delaying carbohydrate digestion and absorption and enhancing insulin action. Br J Nutr. 2007;97:514-21.

Gauttam VK, Kalia AN. Development of polyherbal antidiabetic formulation encapsulated in the phospholipids vesicle system. J Adv Pharm Technol Res. 2013;4:108-17.

Srichamroen A, Thomson A, Field C, Basu TK. In vitro intestinal glucose uptake is inhibited by galactomannan from Canadian fenugreek seeds (Trigonella foenum-graecum ) in genetically lean and obese rats. Nutr Res. 2009;29:49-54.

Khosla P, Gupta D, Nagpal RK. Effect of Trigonella foenum-graecum (fenugreek) on blood glucose in normal and diabetic rats. Indian J Physiol Pharmacol. 1995;39:173-74.

Raju J, Gupta D, Rao AR, Yadvana PK, Baquer NZ. Trigonella foenum-graecum (fenugreek) seed powder improves glucose homestasis in alloxan diabetic rat tissues by reversing the altered glycolytic, gluconeogenic and lipogenic enzymes. Mol Cell Biochem. 2001;224:45-51.

Suskomboon N, Poolsup N, Boonkaew S, Suthisisang C. Meta-analysis of the effect of herbal supplement on glycemic control in type 2 diabetes. J Ethnopharmacol. 2011;137:1328-33.

Ismail MY. Clinical evaluation of antidiabetic activity of Trigonella seeds and Aegle marmelos leaves. World Appl Sci J. 2009;7:1231-34.

Sharma RD. Effect of fenugreek seeds and leaves on blood glucose and serum insulin responses in human subject. Nutr Res.1986;6:1353-64.

Dixit PP, Ghaskadbi SS, Hari M, Devasagayam TP. Antioxidant properties of germinated fenugreek seeds. Phytother Res. 2005;19:977-83.

Gupta D, Raju J, Baquer NZ. Modulation of some gluconeogenic enzyme activities in diabetic rat liver and kidney: effect of antidiabetic compounds. Indian J Expt Biol. 1999;37: 196-99.